Join Renee Willmon, MSc as she demonstrates Health Storylines as a disease-agnostic and customizable platform that connects healthcare stakeholders to engaged patients.
There is often a conflict between the protocol requirements to efficiently demonstrate endpoints in the clinical development stage, relative to the accurate characterization of real-world target patient populations. Renee will demonstrate several technology and data-enabled approaches to capturing relevant data in parallel with clinical development to set up Market Access teams for success as early as possible.
Key Topics Include:
- Introduce methodology to prospectively collect patient-reported data in parallel to phase 3 clinical studies
- Demonstrate the complementarity of existing forms of RWD/RWE with patient reported data
- Highlight the benefit of a patient-centric approach and generation of patient journey data to contextualize real world patterns of care
Presenters
Senior Director, Evidence & Outcomes
Global Market Access
Self Care Catalysts, an Alira Health Company
A results-driven leader with a successful track record of innovating in the health sector through research, Renee has a passion for identifying and facilitating synergies between research and business.
While data drives today's digital world, analysis doesn't always lead to insight. Renee leverages disparate and unexpected sources of data to align research questions with business objectives, and ultimately provides compelling and actionable answers, especially in the areas of Patient Focused Drug Development, Digital Health, and the application of Behavioral Science for Patient Engagement.
Production Partner
Self Care Catalysts, an Alira Health Company
Our Health Storylines Platform is a trusted companion for patients throughout their journey, generating real world evidence along the way. We empower patients to own their role as health consumers, equipping members of the healthcare ecosystem with insight into the real life experiences that drive health outcomes, and facilitating relationships with the partners who will help achieve their goals.
Additional Content From HealthEconomics.Com
Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems
Deepak Sahu, MBA, explains how HEOR studies are important for generating useful effectiveness data for success of medical technologies.
Designing Causal Inference Studies Using Real-World Data
In this webinar, experts provide an overview of causal inference, along with step-by-step guidance to designing these studies using real-world healthcare data.
Social Media Data: Opportunities and Insights for Clinical Research
Hear four experts from ICON and Kap Code provide insights on how to collect, use, analyze, and interpret social media data in different contexts. These experts share knowledge from over fifteen years of successfully developing and adapting algorithms to treat this kind of data.
Related Content
Streamlining Health Technology Assessments by Automating Literature Reviews
Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Watch experts from PHAR, Novartis, and Bausch Health discuss the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.